Moderna Will Ask FDA for Approval of Covid-19 Vaccine Today

Drug maker Moderna plans to apply today for authorization of its Covid-19 vaccine from the FDA. Moderna officials claim it is 100 percent effective at preventing severe cases of Covid-19, according to CNN. Moderna’s clinical trials also show that the two-dose vaccine is 94 percent effective at preventing Covid-19. The company will submit a request for authorization from the European Medicines Agency today as well.

“It was the first time I allowed myself to cry,” Dr. Tal Zaks, Moderna’s chief medical officer, said of the research. “We have a full expectation to change the course of this pandemic.”

Dr. Paul Offit, a member of the vaccine advisory committee at the FDA, referred to Moderna’s results as “amazing data.” Moderna’s research included a 30,000-person clinical trial in which 196 cases of symptomatic COVID-19 were reported, according to The Verge. Out of those cases, 185 people who received a placebo developed Covid-19, and there were 11 cases in people who actually received the vaccine.

Moderna officials claim to be able to have up to 20 million doses of the vaccine — enough for 10 million people — by the end of this year. Pharmaceutical company Pfizer is another company who showed promising results in the Phase 3 of its clinical trial. Its vaccine proved to be 95 percent effective. It is also administered in two doses a few weeks apart. Pfizer officials say the company may be able to provide up to 25 million doses nationwide this year that could be administered to 12.5 million people.